Finance

Lists
NVRS:CNSX
Noveris Health Sciences Inc
CA$0.070
-17.65%
(-0.015) 1D
Sep 16, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NVRS...
Open
CA$0.09
High
CA$0.09
Low
CA$0.07
Mkt. cap
3.87M
Avg. vol.
935.17K
Volume
1.10M
P/E ratio
0.03
52-wk high
CA$3.00
52-wk low
CA$0.07
EPS
CA$2.52
No. of employees
3
Open
CA$0.09
High
CA$0.09
Low
CA$0.07
Mkt. cap
3.87M
Avg. vol.
935.17K
Volume
1.10M
P/E ratio
0.03
52-wk high
CA$3.00
52-wk low
CA$0.07
EPS
CA$2.52
No. of employees
3
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitenoveris.health
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-40.14K
-
-
32.79K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-70.57K
5.04K
316.29K
669.62K
Operating expense
-110.70K
5.04K
316.29K
702.42K
Total operating expenses
-110.70K
5.04K
316.29K
702.42K
Operating income
110.70K
-5.04K
-316.29K
-702.42K
Other non operating income
85.53K
-417.63K
-1.32M
640.56K
EBT including unusual items
73.79K
3.16M
-1.62M
22.81K
EBT excluding unusual items
73.79K
-405.27K
-1.62M
-155.29K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
73.79K
3.16M
-1.62M
22.81K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-26.16K
-12.63K
-9.90K
Net interest expenses
-
-26.16K
-12.63K
-9.90K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps